|
1
|
Petersson F: Nasopharyngeal carcinoma: A
review. Semin Diagn Pathol. 32:54–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zanetti R, Tazi MA and Rosso S: New data
tells us more about cancer incidence in North Africa. Eur J Cancer.
46:462–466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim
A and Bhatia K: The extent of genetic diversity of Epstein-Barr
virus and its geographic and disease patterns: A need for
reappraisal. Virus Res. 143:209–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ho CH, Chen CL, Li WY and Chen CJ: Decoy
receptor 3, upregulated by Epstein-Barr virus latent membrane
protein 1, enhances nasopharyngeal carcinoma cell migration and
invasion. Carcinogenesis. 30:1443–1451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iwakiri D and Takada K: Role of EBERs in
the pathogenesis of EBV infection. Adv Cancer Res. 107:119–136.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dawson CW, Laverick L, Morris MA,
Tramoutanis G and Young LS: Epstein-Barr virus-encoded LMP1
regulates epithelial cell motility and invasion via the ERK-MAPK
pathway. J Virol. 82:3654–3664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang YT, Liu MY, Tsai CH and Yeh TH:
Upregulation of interleukin-1 by Epstein-Barr virus latent membrane
protein 1 and its possible role in nasopharyngeal carcinoma cell
growth. Head Neck. 32:869–876. 2010.PubMed/NCBI
|
|
9
|
AJCC, . LarynxAmerican Joint Committee on
Cancer. AJCC Cancer Staging Manual. 6th. Springer; New York: pp.
47–57. 2002
|
|
10
|
Shanmugaratnam KS and Sobin LH:
Histological typing of upper respiratory tract tumors. Geneva:
World Health Organization; 1978
|
|
11
|
Schag CC, Heinrich RL and Ganz PA:
Karnofsky performance status revisited: Reliability, validity, and
guidelines. J Clin Oncol. 2:187–193. 1984.PubMed/NCBI
|
|
12
|
Lo YM, Chan LY and Lo KW: Quantitative
analysis of cell-free Epstein-Barr virus DNA in plasma of patients
with nasopharyngeal carcinoma. Cancer Res. 59:1188–1191.
1999.PubMed/NCBI
|
|
13
|
Dinarello CA: ELISA kits based on
monoclonal antibodies do not measure total IL-1beta synthesis. J
Immunol Methods. 148:255–259. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gaines-Das RE and Poole S: The
international standard for interleukin-6. Evaluation in an
international collaborative study. J Immunol Methods. 160:147–153.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Kossodo S, Houba V and Grau GE:
Assaying tumor necrosis factor concentrations in human serum. A WHO
international collaborative study. J Immunol Methods. 182:107–114.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kong L, Zhang YW, Hu CS and Guo Y:
Neoadjuvant chemotherapy followed by concurrent chemo-radiation for
locally advanced nasopharyngeal carcinoma. Chin J Cancer.
29:551–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kraemer HC and Theimann S: How many
subjects?Statistical Power Analysis in Research. Newbury Park, CA:
Sage; 1987
|
|
18
|
Murphy KR and Myors B: Statistical power
analysis: A simple and general model for traditional and modern
hypothesis tests. 2nd. Lawrence Erlbaum Associates, Inc.; 2003
|
|
19
|
Adham M, Kurniawan AN, Muhtadi AI, Roezin
A, Hermani B, Gondhowiardjo S, Tan IB and Middeldorp JM:
Nasopharyngeal carcinoma in Indonesia: Epidemiology, incidence,
signs, and symptoms at presentation. Chin J Cancer. 31:185–196.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang
LF, Wang P, Xie SH, Rao HL, Fang F, et al: Evaluation of plasma
Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma
patients from healthy high-risk populations in Southern China.
Cancer. 120:1353–1360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hutajulu SH, Kurnianda J, Tan IB and
Middeldorp JM: Therapeutic implications of Epstein-Barr virus
infection for the treatment of nasopharyngeal carcinoma. Ther Clin
Risk Manag. 10:721–736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stewart S, Dawson CW, Takada K, Curnow J,
Moody CA, Sixbey JW and Young LS: Epstein-Barr virus-encoded LMP2A
regulates viral and cellular gene expression by modulation of the
NF-kappaB transcription factor pathway. Proc Natl Acad Sci USA.
101:15730–15735. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To
KF, Hayward DS, Chui YL, Lau YL, Takada K and Huang DP:
Epstein-Barr virus infection alters cellular signal cascades in
human nasopharyngeal epithelial cells. Neoplasia. 8:173–180. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang G, Tsang CM, Deng W, Yip YL, Lui VW,
Wong SC, Cheung AL, Hau PM, Zeng M, Lung ML, et al: Enhanced
IL-6/IL-6R signaling promotes growth and malignant properties in
EBV-infected premalignant and cancerous nasopharyngeal epithelial
cells. PLoS One. 8:e622842013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ansari MA, Singh VV, Dutta S, Veettil MV,
Dutta D, Chikoti L, Lu J, Everly D and Chandran B: Constitutive
interferon-inducible protein 16-inflammasome activation during
Epstein-Barr virus latency I, II and, III in B and epithelial
cells. J Virol. 87:8606–8623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song Q, Wang G, Chu Y, Zhou L, Jiang M, He
Q, Liu M, Qin J and Hu J: TNF-α up-regulates cellular inhibitor of
apoptosis protein 2 (c-IAP2) via c-Jun N-terminal kinase (JNK)
pathway in nasopharyngeal carcinoma. Int Immunopharmacol.
16:148–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao Q, Zeng Z, Guo X, Li X, Wei F, Zhang
W, Li X, Chen P, Liang F, Xiang B, et al: LPLUNC1 suppresses
IL-6-induced nasopharyngeal carcinoma cell proliferation via
inhibiting the Stat3 activation. Oncogene. 33:2098–2109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu WL, Lin YH, Xiao H, Xing S, Chen H,
Chi PD and Zhang G: Epstein-Barr virus infection induces
indoleamine 2,3-dioxygenase expression in human monocyte-derived
macrophages through p38/mitogen-activated protein kinase and NF-κB
pathways: Impairment in T cell functions. J Virol. 88:6660–6671.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen LC, Wang LJ, Tsang NM, Ojcius DM,
Chen CC, Ouyang CN, Hsueh C, Liang Y, Chang KP, Chen CC and Chang
YS: Tumor inflammasome-derived IL-1β recruits neutrophils and
improves local recurrence-free survival in EBV-induced
nasopharyngeal carcinoma. EMBO Mol Med. 4:1276–1293. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu K, Feng X, Deng Q, Sheng L, Liu P, Xu S
and Su D: Prognostic role of serum cytokines in patients with
nasopharyngeal carcinoma. Onkologie. 35:494–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Visconti L, Nelissen K, Deckx L, van den
Akker M, Adriaensen W, Daniels L, Matheï C, Linsen L, Hellings N,
Stinissen P and Buntinx F: Prognostic value of circulating
cytokines on overall survival and disease-free survival in cancer
patients. Biomark Med. 8:297–306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reitter EM, Ay C, Kaider A, Pirker R,
Zielinski C, Zlabinger G and Pabinger I: Interleukin levels and
their potential association with venous thromboembolism and
survival in cancer patients. Clin Exp Immunol. 177:253–260. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng D, Kong H and Li Y: Prognostic value
of interleukin-8 and MMP-9 in nasopharyngeal carcinoma. Eur Arch
Otorhinolaryngol. 271:503–509. 2014. View Article : Google Scholar : PubMed/NCBI
|
